Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis

@inproceedings{Kehagia2012CognitiveII,
  title={Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis},
  author={Angie A. Kehagia and Roger A. Barker and Trevor W. Robbins},
  booktitle={Neuro-degenerative diseases},
  year={2012}
}
Research into the heterogeneous nature of cognitive impairment documented in patients with Parkinson's disease (PD) has focused on disentangling deficits that vary between individuals, evolve and respond differentially to pharmacological treatments, and relate differentially to PD dementia (PDD). We summarise studies conducted in our laboratory over the last 2 decades, outlining the incremental development of our hypotheses, the starting point for which is our early work on executive deficits… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 74 extracted citations

Exenatide as a novel treatment for Parkinson ’ s disease

Dr Iciar Aviles-Olmos
2013
View 6 Excerpts
Highly Influenced

Parkinson’s disease dementia: a neural networks perspective

Brain : a journal of neurology • 2015
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 79 references

Depression impairs learning whereas anticholinergics impair transfer generalization in Parkinson patients tested on dopaminergic medications.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology • 2010

Dopa - mine agonists diminish value sensitivity of the orbitofrontal cortex : a trigger for pathological gambling in Parkinson ’ s disease ?

T vanEimeren, B Ballanger, +3 authors AP Strafella
Neuropsychopharmacology • 2009

Similar Papers

Loading similar papers…